https://www.eastbaytimes.com/2024/10/21/23andme-explainer/

Emily Bloch | (TNS) The Philadelphia Inquirer

23andMe is facing scrutiny, with some experts calling it the beginning of the end for the popular genetic testing company. It’s been a rocky year for the saliva-based DNA testing brand, including a high-profile data breach and resignations from the company’s board last month.